Simhanada Guggulu in classical Ayurveda

What it is

Simhanada guggulu is a classical tablet from the Bhaishajyaratnavali's Amavata chapter (verses 130–135), combining Triphala, purified sulphur (Gandhaka), purified Guggulu (Commiphora mukul resin), and castor oil (Eranda taila). The classical verses direct it at Vata and Pitta disorders, limping, paralysis, cough, skin disease, gout, abdominal conditions, and Amavata (rheumatoid arthritis).

Classical properties

• Taste (rasa): bitter (Tikta), astringent (Kashaya)
• Qualities (guna): sharp (Tikshna)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Vata and Pitta; may increase Kapha

Traditional use

Traditionally, Simhanada guggulu is the signature formulation for Amavata, a condition of joint swelling, pain, and stiffness resembling rheumatoid arthritis, as well as for general Vata disorders affecting the joints.

What research has looked at

Combination study with topical paste (open, no control)

A 2014 study in the International Journal of Ayurvedic Medicine (Debnath & Vyas, Gujarat Ayurved University, Jamnagar) treated 40 patients with Amavata: Simhanada guggulu orally plus Shatapushpadi lepa applied to affected joints, for 45 days. The authors reported 40% major improvement, 50% minor improvement, and 10% no improvement, with no complete remissions and no adverse drug reactions reported.

Comparative trial versus Shiva guggulu (small randomized comparison)

A comparative study in the International Journal of Applied Pharmaceutics randomized 24 Amavata patients into two groups: Shiva guggulu or Simhanada guggulu, for eight weeks. Simhanada guggulu showed statistically significant improvement in grip strength (37.5% relief) and walking time, outperforming Shiva guggulu. Baseline scores differed between groups, weakening the comparison.

What the evidence does not support (yet)

The Jamnagar study combined the tablet with a topical paste, so effects cannot be attributed to Simhanada guggulu alone. Neither study had a placebo or modern-therapy arm, so none can show superiority over standard rheumatoid arthritis treatment. No study isolates Simhanada guggulu as a single intervention.

Safety notes

The Jamnagar study reported no adverse drug reactions over 45 days, but a 40-patient open study is a thin basis for safety claims. Guggulu preparations can interact with anticoagulant and thyroid medications in principle, and their long-term safety as proprietary products varies by manufacturer quality. Rheumatoid arthritis causes irreversible joint damage if under-treated; relying on an unproven herbal formula instead of disease-modifying treatment is risky. Use only under the joint supervision of a rheumatologist and a qualified Ayurvedic practitioner. No safety data exist for pregnancy or breastfeeding.

FAQs

What is Simhanada guggulu?

It is a classical Ayurvedic guggulu-based tablet used for Amavata, joint inflammation resembling rheumatoid arthritis.

Is it proven for arthritis?

Weakly. Two small studies without placebo arms reported improvement, but one combined it with a topical paste and neither tested it alone against standard care.

Can it replace rheumatoid arthritis medication?

No. RA needs rheumatological diagnosis and disease-modifying treatment to prevent joint destruction. This formula's evidence does not support substitution.

What is the recommended dose?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Why is this article short?

Because the evidence is two small, unblinded studies. Everything else is classical claim.

Is it safe long-term?

Unknown. The longest reported use is 45 days in 40 patients with no adverse events noted, which is not a long-term safety profile.

Sources

• The classical formulation verses (Bhaishajyaratnavali, Amavatadhikara 130–135), ingredient list, and indications: Simhanada Guggulu: Pentacare
• A 2014 clinical study of 40 Amavata (rheumatoid arthritis) patients treated with Simhanada guggulu plus a topical paste for 45 days reported improvement in 90% with no adverse drug reactions: Clinical study on Amavata (rheumatoid arthritis) with Simhanada guggulu and Shatapuspadi lepa
• A comparative trial in 24 Amavata patients found Simhanada guggulu outperformed Shiva guggulu on grip strength and walking time over eight weeks: Comparative study of Shiva guggulu and Simhanada guggulu in the management of Amavata (rheumatoid arthritis)

Disclaimer

This article is for education only and is not medical advice. Simhanada guggulu has weak clinical evidence and no established safety profile. Rheumatoid arthritis requires proper diagnosis and disease-modifying treatment; never use this formula as a substitute.